Lobby organisation
Global Life Sciences Solutions Operations UK Ltd (doing business as Cytiva)
Company · Health & pharma · HQ: Sweden · Transparency Register entry
As of 7 November 2026, Global Life Sciences Solutions Operations UK Ltd (doing business as Cytiva) appears in 7 declared MEP meetings (7 different MEPs), most often with European People's Party.
In their own words
“Cytiva is a global provider of technologies and services that advance and accelerate the development and manufacture of therapeutics. We have a rich heritage tracing back hundreds of years and are part of Danaher Corporation. Our customers undertake life-saving activities ranging from fundamental biological research to developing innovative vaccines, biologic drugs, and novel cell and gene therapies.”
Read the rest of the statementShow less of the statement
“Our job is to supply the tools and services they need to work better, faster and safer, leading to better patient outcomes. As a trusted partner to customers that range in scale and scope, Cytiva brings efficiencies to research and manufacturing workflows, ensuring the development, manufacture and delivery of transformative medicines to patients.”
Stated goals from the organisation's own Transparency Register filing.
Who they meet, and when
Which groups they meet
Share of this organisation's 7 declared meetings, by the meeting MEP's political group.
Meetings by year
Declared meetings per calendar year, 2024–2026. Bar length is relative to its busiest year (3 in 2025). Hatched: 2026 is a part-year - the record runs to 6 Nov 2026.
Group is each MEP's current political group, not necessarily the one they sat with at the time. Shares are rounded to whole percent.
The MEPs they meet most
The 7 most recent declared meetings
| Date | MEP | Subject |
|---|---|---|
| 31 Mar 2026 | Wouter Beke | EU Biotech Act I |
| 26 Feb 2026 | Katri Kulmuni | Biotech I |
| 15 Sep 2025 | Nicolás González Casares | Biotech |
| 24 Jun 2025 | Tiemo Wölken | Pharma Package |
| 24 Feb 2025 | Stine Bosse | European health policy |
| 7 Oct 2024 | Eszter Lakos | Life sciences industry |
| 11 Jan 2024 | Adam Jarubas | EU pharmaceutical market |
Meeting an MEP is a normal part of democratic life; the record is shown so anyone can see it.